We are studying a new treatment for children with severe hemophilia A or B to see if it is safer and more effective than standard care. This trial includes participants with or without inhibitors.
Health conditions and diseases that the clinical trial is designed to study and treat.
Haemophilia is a rare genetic bleeding disorder where the blood does not clot properly due to a deficiency in clotting factors, specifically Factor VIII (Haemophilia A) or Factor IX (Haemophilia B). This can lead to excessive bleeding and bruising.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
